Search results
Column: Pharmacy middlemen claim to keep prescription prices low. In fact, they've cost consumers...
Los Angeles Times· 2 hours agoReferring to a generic version of Gleevec, a leukemia drug taken by nearly 200,000 patients, the...
Health-Care Companies Are Sending Your Data to Big Tech
Bloomberg· 2 hours agoCalifornia-based health system Kaiser Permanente recently alerted millions of people that their...
FTC poised to sue drug middlemen over insulin prices
Axios· 3 hours agoWhy it matters: The planned suit, first reported by the Wall Street Journal, would follow a two-year FTC investigation that found pharmacy benefit...
FTC preparing suit against drug middlemen over insulin rebates
Los Angeles Times· 12 hours agoThe agency has been investigating whether the rebate practices of insulin manufacturers and three ...
Biden health and human services chief rips pharmacy benefit managers during Flint visit
Detroit News· 13 hours agoU.S. Health and Human Services Secretary Xavier Becerra called for funding and policies that support...
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks via Yahoo Finance Canada· 15 hours agoThe most recent trading session ended with CVS Health (CVS) standing at $57.53, reflecting a -0.16%...
Spotlight on PBMs gets harsher
Axios· 15 hours agoThe drumbeat for PBM reforms is intensifying, highlighted by a scathing Federal Trade Commission report on the industry's business practices and a coming...
US FTC to sue drug middlemen over insulin prices, source says
Reuters via Yahoo Canada News· 18 hours agoFederal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over their tactics as...
Pharmacy Out of Ozempic? Here's Exactly What To Do
Parade· 19 hours agoOzempic and other weight loss medications like Wegovy, Zepbound and Mounjaro are more popular than ever. While it's great that we're nixing the stigma,...
FTC to sue drug managers amid insulin price hikes
Investing.com via Yahoo Finance Canada· 20 hours agoInvesting.com - The Federal Trade Commission (FTC) is gearing up to sue the top three pharmacy-benefit managers (PBMs) over their strategies for negotiating drug prices, including ...
